Gingival Enlargement Among Renal Transplant Recipients in the Era of New‐Generation Immunosuppressants
- 1 March 2008
- journal article
- Published by Wiley in The Journal of Periodontology
- Vol. 79 (3), 453-460
- https://doi.org/10.1902/jop.2008.070434
Abstract
Tacrolimus is a new-generation immunosuppressant as successful as cyclosporin in suppressing organ transplant rejection. Although cyclosporin is known to cause gingival enlargement (GE), tacrolimus has not been associated with this condition. We sought to explore the prevalence of GE among renal transplant recipients (RTRs) in relation to cyclosporin and tacrolimus while controlling for the effect of calcium channel blockers (CCBs) and supragingival plaque. RTRs were recruited from our institution's Kidney Transplant Unit. Participants completed a standardized questionnaire and received a complete oral examination, including a soft tissue examination and a periodontal examination measuring probing depth, recession, bleeding on probing, plaque index (PI), and GE. Among 115 RTRs, 39 (34%) presented with GE, with the highest prevalence among those taking cyclosporin and CCBs (76%) and the lowest among tacrolimus users not on a CCB (15%). Tacrolimus was not found to be associated with GE. Cyclosporin was found to be associated with GE in a univariate analysis stratified by the use of CCBs, but multivariate analysis revealed that the only significant risk factors for GE were the use of CCBs and the widespread presence of abundant supragingival plaque (PI > or =2 on >40% of tooth surfaces). This study confirmed that tacrolimus is not associated with GE. Cyclosporin taken at the currently recommended low dosage and not in combination with a CCB may not be associated with a significant risk for GE in individuals with good oral hygiene. CCBs should be avoided among patients taking cyclosporin and those with poor oral hygiene.Keywords
This publication has 37 references indexed in Scilit:
- Prevalence, Severity, and Risk Variables Associated With Gingival Overgrowth in Renal Transplant Subjects Treated Under Tacrolimus or Cyclosporin RegimensThe Journal of Periodontology, 2006
- Cyclosporin‐Induced Gingival Overgrowth: A Clinical–Epidemiological Evaluation of 121 Italian Renal Transplant RecipientsThe Journal of Periodontology, 2005
- Prevalence and risk of gingival overgrowth in patients treated with diltiazem or verapamilJournal of Clinical Periodontology, 2005
- Three-year posttransplant graft survival in renal-transplant patients with graft function at 6 months receiving tacrolimus or cyclosporine microemulsion within a triple-drug regimenTransplantation, 2003
- Reduction of gum enlargement in stable renal allograft cyclosporin recipients converted to tacrolimus (prograf®)Nephrology, 2002
- Reduction of Severe Gingival Overgrowth in a Kidney Transplant Patient by Replacing Cyclosporin A With TacrolimusThe Journal of Periodontology, 2000
- Manual periodontal probing in supportive periodontal treatmentPeriodontology 2000, 1996
- Cyclosporin, Nifedipine and gingival hyperplasia: a randomized controlled studyTransplant International, 1994
- Periodontal Disease in Pregnancy II. Correlation Between Oral Hygiene and Periodontal ConditionActa Odontologica Scandinavica, 1964
- Studies on Dental Caries: I. Dental Status and Dental Needs of Elementary School ChildrenPublic Health Reports (1896-1970), 1938